The hepatic ChREBP expression and hyperinsulinemia in mice.
- Author:
Li-Wei HUANG
;
Xiao-Meng YANG
;
Xiao-Lin ZHANG
;
Li WANG
;
Li WANG
- Publication Type:Journal Article
- MeSH:
Animals;
Blood Glucose;
metabolism;
Hyperglycemia;
metabolism;
Hyperinsulinism;
metabolism;
Insulin;
blood;
Liver;
metabolism;
Mice;
Mice, Inbred C57BL;
Nuclear Proteins;
metabolism;
Transcription Factors;
metabolism
- From:
Acta Pharmaceutica Sinica
2014;49(6):882-887
- CountryChina
- Language:Chinese
-
Abstract:
To explore the effects of serum insulin on the expression of ChREBP, ACC and FAS in vivo, KKAy mice which were characterized with high levels of both serum insulin and glucose and DIO mice which were characterized with high serum insulin level alone were utilized, separately. The age-matched C57BL/6J mice fed with standard chow were used as normal control (Con). Expressions of hepatic ChREBP, ACC and FAS were detected by Western blotting. As the results, in KKAy mice, a positive correlation between the levels of serum insulin and glucose (r = 0.902, P < 0.000), as well as between the levels of serum insulin and TG (r = 0.732, P < 0.000), was observed. Meanwhile, the expressions of hepatic ChREBP, ACC and FAS increased significantly and accompanied with its hyperinsulinemia and hyperglycemia, separately. In DIO mice, correlation between the levels of serum insulin and TG (r = 0.722, P < 0.001) also showed positive, and the expressions of hepatic ChREBP, ACC and FAS increased significantly and also accompanied with its hyperinsulinemia. However, their blood glucose values were almost normal. These demonstrated that hyperinsulinemia may cause glycolipid metabolic disorders by up-regulating the expression of ChREBP in vivo.
